Trials / Completed
CompletedNCT02229643
Serum Neuroglobin and Nogo-A Concentrations in Acute Traumatic Brain Injury
Neuroglobin and Nogo-A as Biomarkers for the Prognosis of Closed Traumatic Brain Injury
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 34 (actual)
- Sponsor
- Shanghai 6th People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Neuroglobin has been described as a marker of traumatic brain injury. Nogo-A plays an important role in mediating neuroanatomical plasticity and functional recovery following traumatic brain injury. The investigators sought to examine the changes in serum neuroglobin and Nogo-A concentrations in patients with traumatic brain injury during the initial 96-h posttraumatic period and assessed the relation of neuroglobin and Nogo-A to Glasgow Coma Score and prognosis of such patients with traumatic brain injury.
Conditions
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2013-06-01
- Completion
- 2014-06-01
- First posted
- 2014-09-01
- Last updated
- 2020-08-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02229643. Inclusion in this directory is not an endorsement.